Patent Yard Sign in
Expired Canadian patentCanada

Isoindolin-1-one derivative and anti-arrhythmic agent

CA 1284647 C · Owner: Obase, Hiroyuki · Inventors: Oshima, Etsuo; Obase, Hiroyuki; Oiji, Yoshimasa

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Isoindolin-1-one compounds represented by the following formula (I);, (I), {wherein n represents an integer of 1 to 6; m represents 0 or 1; R1, R2 and R3 are each independently hydrogen or lower alkyl, and when m is 1, R1 and one of R2 and R3 may form a five-membered or six-membered ring over N atom; X represents hydrogen or hydroxy; Ar represents naphthyl pyridyl or, substituted phenyl represented by the formula (II); Ar and X may form a lactone ring;, (II), wherein Y represents carboxyl lower alkoxycarbonyl, carbamoyl, N,N-lower alkyl-substituted carbamoyl or amino represented by the formula (III):, (III) (wherein R6 and R7 are each independently hydrogen lower, alkyl or lower alkanoyl); …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Granted June 4, 1991. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended June 4, 2008.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledDecember 22, 1987
GrantedJune 4, 1991
Term endedJune 4, 2008
Patent numberCA 1284647 C
Classification (IPC)C07D209/46 +2 more

Timeline

Timeline From CIPO dates

1988199119941997200020032006Application filedDec 22, 1987Patent grantedJune 4, 1991Term endedJune 4, 2008

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.